Abstract library

8 results for "Caroli-Bosc".
#2867 Experience of Treatment with Everolimus in Patients with Well-Differentiated Neuroendocrine Tumors (NET) of Various Localizations at the NN Blokhin NMRCO, Moscow, Russia
Introduction: Everolimus (EVE) (mTOR inhibitor) is an effective drug in the treatment of well-differentiated NETs of different localizations, however, prognostic factors for the correct choice of therapy are not well understood.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Medical treatment - Targeted therapies
Presenting Author: Anna Kuznetsova
#49 Twenty-year experience in diagnosis and treatment of insulinoma in Burdenko Surgery Clinic, Moscow Medical Academy, Russia
Introduction: For the last 20 years, 235 patients with the diagnosis of organic hyperinsulinismus were treated in Burdenko Surgery Clinic.
Conference: 7th Annual ENETS Conference (2010)
Category: Basic
Presenting Author: Prof Alexey Egorov
#221 Diagnostic Algorithm of Pancreatic Neuroendocrine Tumors
Introduction: Diagnostics of pNETs is associated with certain problems due to a variety of clinical features, including a rather small size of primaries and, quite often, multiple lesions.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Ivan A Vasiliev
#499 Effect of Everolimus on Pharmacokinetics of Octreotide LAR in Patients with Advanced Neuroendocrine Tumors: A RADIANT-2 Analysis
Introduction: In RADIANT-2 (NCT00412061), Everolimus (E) plus Octreotide LAR (O) exhibited a clinically meaningful 5.1-month improvement in progression-free survival (PFS) v. placebo plus octreotide LAR (P+O) in patients (pts) with advanced neuroendocrine tumors (NET) and a history of carcinoid syndrome.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Marianne E Pavel
#755 Surgical Treatment of Pancreatic Neuroendocrine Tumors
Introduction: In the surgical department of First Moscow State Medical University, 335 patients with pNETs were operated on.
Conference: 10th Annual ENETS Conference 2013 (2013)
Category: Clinical cases/reports
Presenting Author: Ivan Vasiliev
#916 PET+10 Study: Efficacy of Platin/Etoposide Combination in Well-Differentiated Pancreatic Neuroendocrine Tumors with Ki-67 ≥ 10%
Introduction: Platin-etoposide (PE), the gold standard regimen for poorly differentiated neuroendocrine carcinomas, might be effective in well-differentiated pancreatic neuroendocrine tumors (WD-PNETs) with a high Ki-67 proliferation index.
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Medical treatment - Chemotherapy
Presenting Author: Dr Guillaume Roquin
#1701 Characteristics of Bronchopulmonary Carcinoids in Cancer Centre Database in Moscow
Introduction: Bronchopulmonary carcinoids (BC) represent 1% of lung cancers and comprise typical (TC), atypical carcinoids (AC), small cell lung cancer (SCLC) and large cell cancer.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Epidemiology/Natural history/Prognosis - Registries, nationwide and regional surveys
Presenting Author: Vera Gorbunova
Keywords: registry, lung
#2009 Retrospective Epidemiologic Study of Medullary Cancer of Thyroid Gland in Hospital – Based Registry in Moscow Cancer Centre
Introduction: Medullary cancer of thyroid gland comes from calcitonin secreting C-cells.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Epidemiology/Natural history/Prognosis- Registries, nationwide and regional surveys
Presenting Author: Liudmila Komarova
Keywords: registry, NETs